Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Praised in Technical420 Article
Lexaria Bioscience Corp. featured in a Technical420 article praising the company’s recent developments Lexaria is improving and strengthening patent portfolio;…
Lexaria Bioscience Corp. featured in a Technical420 article praising the company’s recent developments Lexaria is improving and strengthening patent portfolio;…
Fundamental value drivers of InMed Pharmaceuticals are its drug development pipeline and proprietary biosynthesis technology in cannabinoid manufacturing Biopharmaceutical company…
Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) this morning announced its agreement with a national sales and business development…
Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its purchase of the $Weed cryptocurrency from joint venture partner…
Millions of Americans live in areas with little or no comprehensive health care MIHI establishing nationwide telemedicine network to provide…
EdTech innovator ProBility Media (OTCQB: PBYA) has completed its acquisition of Cranbury International, a Vermont-based exporter of educational and training…
Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has appointed Keevin Gillespie as acting president of…
Specialized holding company SinglePoint, Inc. (OTC: SING) this morning offered a first-hand look at its new bitcoin exchange aimed at…
Technology that improves bioavailability of orally ingested cannabinoids Safer approach that mitigates risks from carcinogens Generates revenue by out-licensing its…
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds,…